Tradjenta and Cirrhosis alcoholic - a phase IV clinical study of FDA data
Cirrhosis alcoholic is reported only by a few people who take Tradjenta.
The phase IV clinical study analyzes which people take Tradjenta and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 9,230 people who have side effects while taking Tradjenta from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
9,230 people reported to have side effects when taking Tradjenta.
Among them, 1 person (0.01%) has Cirrhosis alcoholic.
What is Tradjenta?
Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 8,827 Tradjenta users for its effectiveness, alternative drugs and more.
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 363 drugs and 162 conditions by eHealthMe.
Number of Tradjenta and Cirrhosis alcoholic reports submitted per year:
Gender of people who have Cirrhosis alcoholic when taking Tradjenta *:
- female: 0.0 %
- male: 100 %
Age of people who have Cirrhosis alcoholic when taking Tradjenta *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Tradjenta *:
- Vitamin B12: 1 person, 100.00%
- Levemir: 1 person, 100.00%
- Auryxia: 1 person, 100.00%
- Aranesp: 1 person, 100.00%
Common side effects people have besides Cirrhosis alcoholic *:
- Weight Loss: 1 person, 100.00%
- Stress And Anxiety: 1 person, 100.00%
- Presyncope: 1 person, 100.00%
- Iron Metabolism Disorder: 1 person, 100.00%
- Haemochromatosis (body to absorb more iron than usual from food): 1 person, 100.00%
- Gastritis (inflammation of stomach): 1 person, 100.00%
- Fatigue (feeling of tiredness): 1 person, 100.00%
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 1 person, 100.00%
- Carotid Artery Stenosis (narrowing of carotid artery): 1 person, 100.00%
- Carotid Artery Occlusion (artery blockage): 1 person, 100.00%
Common conditions people have *:
- Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tradjenta and have Cirrhosis alcoholic?Check whether Cirrhosis alcoholic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cirrhosis alcoholic and when was it recovered:
Expand to all the drugs that have ingredients of linagliptin:
Alternative drugs to, pros and cons of Tradjenta:
- Tradjenta (8,827 reports)
Common Tradjenta side effects:
Browse all side effects of Tradjenta:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cirrhosis alcoholic treatments and more:
- Cirrhosis alcoholic (749 reports)
COVID vaccines that are related to Cirrhosis alcoholic:
- Cirrhosis alcoholic in Moderna COVID Vaccine
- Cirrhosis alcoholic in Pfizer BioNTech Covid Vaccine
- Cirrhosis alcoholic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (363 drugs)
All the conditions that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (162 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on linagliptin (the active ingredients of Tradjenta) and Tradjenta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Norco and Bronchiectasis - 4 seconds ago
- Linezolid and Levocarnitine drug interaction - 4 seconds ago
- Solifenacin Succinate and Tremor Aggravated - 5 seconds ago
- Selenium Sulfide and Prilosec drug interaction - 7 seconds ago
- Keflex and Concussion - 9 seconds ago
- Gastric Disorder and Asthma - 10 seconds ago
- Erythromycin Ethylsuccinate and Paleness - 17 seconds ago
- Ovarian Cancer and Abdominal Pain Upper - 17 seconds ago
- Climara and Calcitriol drug interaction - 23 seconds ago
- Gabitril and Tumor - 36 seconds ago